|
FAM63B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.41380265669977E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.90670043590069E-10 |
| Normal-vs-Stage2 |
1.58009999529085E-08 |
| Normal-vs-Stage3 |
1.11950448911102E-11 |
| Normal-vs-Stage4 |
2.88491452948847E-12 |
| Stage1-vs-Stage2 |
8.364000E-01 |
| Stage1-vs-Stage3 |
9.609600E-02 |
| Stage1-vs-Stage4 |
1.190070E-02 |
| Stage2-vs-Stage3 |
3.601600E-01 |
| Stage2-vs-Stage4 |
1.184200E-01 |
| Stage3-vs-Stage4 |
3.657000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.48510126208157E-11 |
| Normal-vs-AfricanAmerican |
9.518899999994E-05 |
| Normal-vs-Asian |
3.12300185711933E-11 |
| Caucasian-vs-AfricanAmerican |
3.003400E-01 |
| Caucasian-vs-Asian |
2.935400E-01 |
| AfricanAmerican-vs-Asian |
8.770000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.19941859064465E-12 |
| Normal-vs-Female |
1.71159975081991E-10 |
| Male-vs-Female |
3.222300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.2005509353894E-12 |
| Normal-vs-Age(41-60Yrs) |
2.59829935345124E-11 |
| Normal-vs-Age(61-80Yrs) |
2.01529903876008E-11 |
| Normal-vs-Age(81-100Yrs) |
1.217850E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.599440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.255200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.401000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.853000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.315600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.481000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.819400E-03 |
| Classical-VS-Follicular |
5.430600E-01 |
| Classical-VS-Other |
2.088600E-01 |
| Classical-VS-Normal |
5.98039950894247E-10 |
| Tall-VS-Follicular |
5.353600E-02 |
| Tall-VS-Other |
8.077400E-01 |
| Tall-VS-Normal |
3.59923202353229E-12 |
| Follicular-VS-Other |
3.293000E-01 |
| Follicular-VS-Normal |
8.6666995802176E-10 |
| Other-VS-Normal |
4.181200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.62280214108546E-11 |
| Normal-vs-N1 |
5.72769609519241E-11 |
| N0-vs-N1 |
3.713000E-01 |
|
|
